- Corporate Officers - T
- Tobin James R
Insider Trading History of Tobin James R
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tobin James R since 2008.
This trader's CIK number is 1190128.
At the time of last reporting, Tobin James R was the Officer of Transmedics Group, Inc.. (stock ticker symbol TMDX).
Also see all insider trading activities at Transmedics Group, Inc..
Note that in the past
TOBIN JAMES R also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Curis Inc (CRIS) by Tobin James R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | CRIS | 0 | $0 | 0 | $0 | 62,500 | $151,875 |
| 2012 | CRIS | 0 | $0 | 0 | $0 | 77,500 | $100,362 |
| 2011 | CRIS | 0 | $0 | 11,987 | $39,197 | 12,500 | $39,125 |
Yearly summary of insider trading at Transmedics Group, Inc. (TMDX) by Tobin James R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | TMDX | 0 | $0 | 47,065 | $6,313,230 | 0 | $0 |
| 2023 | TMDX | 0 | $0 | 20,000 | $1,452,700 | 0 | $0 |
| 2022 | TMDX | 0 | $0 | 145,546 | $5,090,223 | 0 | $0 |
| 2021 | TMDX | 0 | $0 | 10,168 | $340,526 | 0 | $0 |
Yearly summary of insider trading at Boston Scientific Corp (BSX) by Tobin James R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | BSX | 0 | $0 | 0 | $0 | 450,000 | $2,758,500 |
Yearly summary of insider trading at Globus Medical Inc (GMED) by Tobin James R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | GMED | 0 | $0 | 23,334 | $1,602,666 | 23,334 | $1,059,773 |
| 2021 | GMED | 0 | $0 | 25,000 | $1,798,999 | 25,000 | $1,094,250 |
| 2020 | GMED | 0 | $0 | 23,000 | $1,264,920 | 23,000 | $604,210 |
| 2019 | GMED | 0 | $0 | 37,000 | $1,759,333 | 37,000 | $937,190 |
Insider trading activities at 4 companies by Tobin James R:
1. Curis Inc (CRIS)
2. Transmedics Group, Inc. (TMDX)
3. Boston Scientific Corp (BSX)
4. Globus Medical Inc (GMED)
Table 1. Insider trading of Curis Inc (CRIS) by Tobin James R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-05-06 | CRIS | Option Ex | 62,500 | 2.43 | 151,875 |
| 2012-03-08 | CRIS | Option Ex | 77,500 | 1.29 | 100,362 |
| 2011-03-30 | CRIS | Option Ex | 12,500 | 3.13 | 39,125 |
| 2011-03-30 | CRIS | Sale | 11,987 | 3.27 | 39,197 |
Table 2. Insider trading of Transmedics Group, Inc. (TMDX) by Tobin James R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-08-08 | TMDX | Sale | 20,000 | 159.46 | 3,189,200 |
| 2024-05-03 | TMDX | Sale | 12,025 | 125.01 | 1,503,245 |
| 2024-05-01 | TMDX | Sale | 15,040 | 107.77 | 1,620,785 |
| 2023-11-28 | TMDX | Sale | 10,000 | 70.14 | 701,400 |
| 2023-02-23 | TMDX | Sale | 10,000 | 75.13 | 751,300 |
| 2022-07-29 | TMDX | Sale | 48,515 | 39.98 | 1,939,629 |
| 2022-07-05 | TMDX | Sale | 48,515 | 35.00 | 1,698,025 |
| 2022-05-04 | TMDX | Sale | 48,516 | 29.94 | 1,452,569 |
| 2021-02-09 | TMDX | Sale | 10,168 | 33.49 | 340,526 |
Table 3. Insider trading of Boston Scientific Corp (BSX) by Tobin James R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-10-09 | BSX | Option Ex | 350,000 | 6.13 | 2,145,500 |
| 2008-02-07 | BSX | Option Ex | 100,000 | 6.13 | 613,000 |
Table 4. Insider trading of Globus Medical Inc (GMED) by Tobin James R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-03-15 | GMED | Sale | 8,850 | 65.47 | 579,418 |
| 2022-03-15 | GMED | Option Ex | 8,850 | 48.42 | 428,561 |
| 2022-03-08 | GMED | Option Ex | 4,484 | 43.58 | 195,412 |
| 2022-03-10 | GMED | Option Ex | 10,000 | 43.58 | 435,800 |
| 2022-03-08 | GMED | Sale | 4,484 | 72.00 | 322,848 |
| 2022-03-10 | GMED | Sale | 10,000 | 70.04 | 700,400 |
| 2021-05-10 | GMED | Option Ex | 25,000 | 43.77 | 1,094,250 |
| 2021-05-10 | GMED | Sale | 25,000 | 71.96 | 1,798,999 |
| 2020-09-02 | GMED | Option Ex | 5,600 | 26.27 | 147,112 |
| 2020-09-02 | GMED | Sale | 5,600 | 56.85 | 318,360 |
| 2020-08-25 | GMED | Option Ex | 17,400 | 26.27 | 457,098 |
| 2020-08-25 | GMED | Sale | 17,400 | 54.40 | 946,560 |
| 2019-02-28 | GMED | Option Ex | 28,100 | 25.51 | 716,915 |
| 2019-02-26 | GMED | Sale | 8,900 | 47.48 | 422,616 |
| 2019-02-26 | GMED | Option Ex | 8,900 | 24.75 | 220,275 |
| 2019-02-28 | GMED | Sale | 28,100 | 47.57 | 1,336,717 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Tobin James R
(Officer of Transmedics Group, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.